JPMorgan Chase and Eldridge join the investor group to extend the company's latest funding round.
"I’m delighted to welcome JPMorgan Chase and Eldridge to our world-class group of investors as we continue to strengthen and expand our local and alternative payment capabilities,"
The seed round was backed by private investors establishing QantX Ventures to fund clinical development.
"We are excited to become part of the Neuronostics journey, they have pioneered innovative technology that will make a significant positive difference to the lives of many people around the world."
The round was co-led by Worth Capital and Loyal VC, incorporating angel investment and a Seedrs campaign.
"I am thrilled not only to close a successful $1.5m fundraise but to share our journey and vision with over 900 investors, many who came through crowdfunding platform Seedrs. Having the backing and mentorship in the guise of Worth Capital, Loyal VC and our advisors puts us in a strong position for hypergrowth"
The seed round was led by Creandum to fund further customer growth and product development.
"We know from speaking to our users that one of the biggest challenges they face is the ability to manage their payment-related admin tasks effectively and efficiently, whilst also growing their services and attracting more customers. At a time when the self-employed are already taking a hit due to the pandemic, reducing the cost of getting paid and making the process much faster is becoming increasingly important."